Literature DB >> 24436305

Impact of human pathogenic micro-insertions and micro-deletions on post-transcriptional regulation.

Xinjun Zhang1, Hai Lin, Huiying Zhao, Yangyang Hao, Matthew Mort, David N Cooper, Yaoqi Zhou, Yunlong Liu.   

Abstract

Small insertions/deletions (INDELs) of ≤21 bp comprise 18% of all recorded mutations causing human inherited disease and are evident in 24% of documented Mendelian diseases. INDELs affect gene function in multiple ways: for example, by introducing premature stop codons that either lead to the production of truncated proteins or affect transcriptional efficiency. However, the means by which they impact post-transcriptional regulation, including alternative splicing, have not been fully evaluated. In this study, we collate disease-causing INDELs from the Human Gene Mutation Database (HGMD) and neutral INDELs from the 1000 Genomes Project. The potential of these two types of INDELs to affect binding-site affinity of RNA-binding proteins (RBPs) was then evaluated. We identified several sequence features that can distinguish disease-causing INDELs from neutral INDELs. Moreover, we built a machine-learning predictor called PinPor (predicting pathogenic small insertions and deletions affecting post-transcriptional regulation, http://watson.compbio.iupui.edu/pinpor/) to ascertain which newly observed INDELs are likely to be pathogenic. Our results show that disease-causing INDELs are more likely to ablate RBP-binding sites and tend to affect more RBP-binding sites than neutral INDELs. Additionally, disease-causing INDELs give rise to greater deviations in binding affinity than neutral INDELs. We also demonstrated that disease-causing INDELs may be distinguished from neutral INDELs by several sequence features, such as their proximity to splice sites and their potential effects on RNA secondary structure. This predictor showed satisfactory performance in identifying numerous pathogenic INDELs, with a Matthews correlation coefficient (MCC) value of 0.51 and an accuracy of 0.75.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24436305      PMCID: PMC4014196          DOI: 10.1093/hmg/ddu019

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  65 in total

Review 1.  Mitochondrial proteins and complexes in Leishmania and Trypanosoma involved in U-insertion/deletion RNA editing.

Authors:  Larry Simpson; Ruslan Aphasizhev; Guanghan Gao; Xuedong Kang
Journal:  RNA       Date:  2004-02       Impact factor: 4.942

2.  Deciphering the splicing code.

Authors:  Yoseph Barash; John A Calarco; Weijun Gao; Qun Pan; Xinchen Wang; Ofer Shai; Benjamin J Blencowe; Brendan J Frey
Journal:  Nature       Date:  2010-05-06       Impact factor: 49.962

3.  Analysis and design of RNA sequencing experiments for identifying isoform regulation.

Authors:  Yarden Katz; Eric T Wang; Edoardo M Airoldi; Christopher B Burge
Journal:  Nat Methods       Date:  2010-11-07       Impact factor: 28.547

Review 4.  Colorectal cancer and genetic alterations in the Wnt pathway.

Authors:  S Segditsas; I Tomlinson
Journal:  Oncogene       Date:  2006-12-04       Impact factor: 9.867

5.  Linking C5 deficiency to an exonic splicing enhancer mutation.

Authors:  Nicole Pfarr; Dirk Prawitt; Michael Kirschfink; Claudia Schroff; Markus Knuf; Pirmin Habermehl; Wilma Mannhardt; Fred Zepp; William G Fairbrother; William Fairbrother; Michael Loos; Christopher B Burge; Joachim Pohlenz
Journal:  J Immunol       Date:  2005-04-01       Impact factor: 5.422

Review 6.  Transcription factors and congenital heart defects.

Authors:  Krista L Clark; Katherine E Yutzey; D Woodrow Benson
Journal:  Annu Rev Physiol       Date:  2006       Impact factor: 19.318

7.  Splicing factor SFRS1 recognizes a functionally diverse landscape of RNA transcripts.

Authors:  Jeremy R Sanford; Xin Wang; Matthew Mort; Natalia Vanduyn; David N Cooper; Sean D Mooney; Howard J Edenberg; Yunlong Liu
Journal:  Genome Res       Date:  2008-12-30       Impact factor: 9.043

8.  Chemical shift mapping of RNA interactions with the polypyrimidine tract binding protein.

Authors:  Xuemei Yuan; Natalia Davydova; Maria R Conte; Stephen Curry; Stephen Matthews
Journal:  Nucleic Acids Res       Date:  2002-01-15       Impact factor: 16.971

9.  Predicting sequence and structural specificities of RNA binding regions recognized by splicing factor SRSF1.

Authors:  Xin Wang; Liran Juan; Junjie Lv; Kejun Wang; Jeremy R Sanford; Yunlong Liu
Journal:  BMC Genomics       Date:  2011-12-23       Impact factor: 3.969

10.  Predicting the effects of frameshifting indels.

Authors:  Jing Hu; Pauline C Ng
Journal:  Genome Biol       Date:  2012-02-09       Impact factor: 13.583

View more
  14 in total

Review 1.  Novel genetic and epigenetic factors of importance for inter-individual differences in drug disposition, response and toxicity.

Authors:  Volker M Lauschke; Yitian Zhou; Magnus Ingelman-Sundberg
Journal:  Pharmacol Ther       Date:  2019-01-22       Impact factor: 12.310

2.  Distinct genetic landscape and a low response to doxorubicin in a luminal-A breast cancer cell line of Pakistani origin.

Authors:  Muhammad Shakeel; Salman Ahmed Khan; Anum Jabeen Mughal; Muhammad Irfan; Daniel C Hoessli; M Iqbal Choudhary; Muhammad Aurongzeb; Ishtiaq Ahmad Khan
Journal:  Mol Biol Rep       Date:  2021-09-08       Impact factor: 2.316

3.  Comparison of insertion/deletion calling algorithms on human next-generation sequencing data.

Authors:  Dalia H Ghoneim; Jason R Myers; Emily Tuttle; Alex R Paciorkowski
Journal:  BMC Res Notes       Date:  2014-12-01

4.  Leveraging multiple genomic data to prioritize disease-causing indels from exome sequencing data.

Authors:  Mengmeng Wu; Ting Chen; Rui Jiang
Journal:  Sci Rep       Date:  2017-05-11       Impact factor: 4.379

Review 5.  The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies.

Authors:  Peter D Stenson; Matthew Mort; Edward V Ball; Katy Evans; Matthew Hayden; Sally Heywood; Michelle Hussain; Andrew D Phillips; David N Cooper
Journal:  Hum Genet       Date:  2017-03-27       Impact factor: 4.132

Review 6.  The Expanding Landscape of Alternative Splicing Variation in Human Populations.

Authors:  Eddie Park; Zhicheng Pan; Zijun Zhang; Lan Lin; Yi Xing
Journal:  Am J Hum Genet       Date:  2018-01-04       Impact factor: 11.025

7.  Bi-allelic c.181_183delTGT in BTB domain of KLHL7 is associated with overlapping phenotypes of Crisponi/CISS1-like and Bohring-Opitz like syndrome.

Authors:  Anil Kanthi; Malavika Hebbar; Stephanie L Bielas; Katta M Girisha; Anju Shukla
Journal:  Eur J Med Genet       Date:  2018-08-22       Impact factor: 2.708

8.  The role of small in-frame insertions/deletions in inherited eye disorders and how structural modelling can help estimate their pathogenicity.

Authors:  Panagiotis I Sergouniotis; Stephanie J Barton; Sarah Waller; Rahat Perveen; Jamie M Ellingford; Christopher Campbell; Georgina Hall; Rachel L Gillespie; Sanjeev S Bhaskar; Simon C Ramsden; Graeme C Black; Simon C Lovell
Journal:  Orphanet J Rare Dis       Date:  2016-09-14       Impact factor: 4.123

9.  regSNPs-splicing: a tool for prioritizing synonymous single-nucleotide substitution.

Authors:  Xinjun Zhang; Meng Li; Hai Lin; Xi Rao; Weixing Feng; Yuedong Yang; Matthew Mort; David N Cooper; Yue Wang; Yadong Wang; Clark Wells; Yaoqi Zhou; Yunlong Liu
Journal:  Hum Genet       Date:  2017-04-08       Impact factor: 5.881

10.  CRISPR-Trap: a clean approach for the generation of gene knockouts and gene replacements in human cells.

Authors:  Stefan Reber; Jonas Mechtersheimer; Sofia Nasif; Julio Aguila Benitez; Martino Colombo; Michal Domanski; Daniel Jutzi; Eva Hedlund; Marc-David Ruepp
Journal:  Mol Biol Cell       Date:  2017-11-22       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.